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 The Landscape of Mass Mediated  
Articulations of Biotechnology  
 
 
 
The objective of this paper is to explore the associations made in mass mediated 
articulations of biotechnology. It serves as the basis for further analyses of mass 
mediated controversies and the purpose is to establish a map of the landscape of 
mass mediated articulation of biotechnology. Which kinds of genetic research 
and technology are articulated in what way? What can be associated to what in 
the mass mediation and when is it portrayed as controversial? In short this is a 
study of associations in the news production that serves as a way of establishing 
an empirical archive for further work. It is based on a relational ontology 
inspired by French philosopher Bruno Latour, supplemented with the method of 
content analysis developed within sociology of mass media. The aim is to study 
the production of networks of articulation in mass media by looking at the 
outcome (the articles), which they produce.  
 
A comprehensive description of mass media analysis inspired by Latour (1999a; 
1999b; 1996; 1987; 1986) is presented in Horst (2003). Here it suffices to say 
that any mass mediated article about biotechnology is the productive result of 
efforts to associate certain occurrences with other occurrences and phenomena 
in a certain way including reference to certain sources with the aim of creating a 
newsworthy story. Each article can therefore be seen as a set of associations and 
the object of this study is to describe these associations. I have found that the 
method of content analysis within media sociology provided a useful starting 
point for such an analysis (Gunter 2000; Pedersen et al. 2000; Lund 1997; 
McQuail 1994). The objective of content analysis is to study the content of an 
amount of mass mediated articles, in order to search for patterns according to 
some sort of coding scheme. I have, however, had to shape this methodology in 
particular ways so that it could function within the overall methodological 
framework of the relational ontology.  
 
A relational ontology implies that the phenomena associated in networks do not 
have any independently determined identity, but rather that they are the result of 
the particular construction of associations in particular way. In this context it 
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means that the content analysis has to be designed as an inductive analysis – 
exploring networks of articulation by inductively exploring what kinds of 
categories can be used to characterise content. Thus, the coding scheme and the 
construction of the different variables and categories are as much the outcome of 
the analysis as the quantitative figures describing their frequency. The 
interpretative work put into the construction of reliable variables and definitions 
of categories are equally important for the description of the topology of the 
articulation of genetics as the quantitative measure of frequencies. 
 
 
Constructing the archive 
The indeterminacy of phenomena does not just pertain to categories of content, 
but also to the overall object of study. How is it possible to identify a particular 
set of mass mediated article that can function as a credible and valid archive for 
the exploration of associations? In short this is a question of how to define the 
archive, and this poses rather many challenges in this connections. As a starting 
point I have chosen to follow the distinction between ‘red’ and ‘green’ 
biotechnology (Bauer 2002) and limit the object of study to ‘red’ biotechnology, 
that is, human genetics primarily applied within the health care services, but also 
forensic applications fall under this category. Agricultural (‘green’) 
biotechnology is left out because it is possible to detect a rather clear distinction 
between the two different applications and focusing on one of them makes it 
simpler to construct reliable categories for the coding scheme.  
 
But this still leaves the problem of unity or at least relations in a sample of 
articles. Is it possible to identify a related sample of articles, which allows the 
analyst to treat the stories as a coherent set of data. Articulation of health care 
related biotechnology occurs in a lot of different types of articles. As news from 
scientific frontiers or political debates on regulations, as human interest stories 
about patients with great hopes and fears, as contributions to ongoing 
controversies on how to employ the new technologies an so forth. They also 
come in different genres from news reports to interviews, editorials and letters to 
the editor. Sometimes the articulation of biotechnology is the main focus of an 
article and sometimes it is a frame of reference or a side story. This touches 
upon a second problem, that of delimiting the object of study. What are not 
articulations of biotechnology? When is the reference to biotechnology so 
peripheral, that it makes more sense to leave an article out of the archive?  
  5
These difficulties in defining the object have been essential in the way I have 
designed the data collection. Instead of narrowing the object of study down to a 
central definition I have expanded the term biotechnology by creating a long list 
of keywords. In this way, the term ‘red’ biotechnology has come to signify a 
diverse and dispersed object of discourse artificially constructed on the basis of 
a list of approximately 30 keywords. The list was created by pilot studies, where 
I collected some 250 articles1 and then kept adding new keywords until I was 
sure to include all of these 250 articles. After this initial construction, the list 
functioned as a search mechanism, whereby I could search the media for articles 
that included one or more of these keywords.  
 
A preliminary archive could then be established as the total of mass mediated 
articles, which included these keywords2. In this way the definition of 
‘articulation of biotechnology’ has been very inclusive, although this archive 
was later reduced to include only articles where biotechnology were given a 
substantial role in the article. Substantial was in this context defined as more 
than a single sentence, rather it had to be topic of articulation in a full paragraph 
or so. The problem of delimitation of the archive has therefore been dealt with 
as an integrated part of the analysis, not as a problem to be managed before the 
‘real’ analysis. It should be noted that establishing the archive is of course 
contingent in that it could have been done in other ways. But it is not arbitrary – 
and the reason for describing the delimiting actions in detail is exactly to make 
this point clear.  
 
It should also be noted that the data unit in this archive is the article, which is 
not necessarily the same as the unit of story. For this study of associations it was 
found to be acceptable. First of all because it most often makes sense to say that 
an article covers one story, simply by being one article, although the same story 
in other relations can be seen to be composed of many stories. Secondly, it is the 
most valid way of counting frequencies in a content analysis. And thirdly, 
subsequent analyses will employ other ways of analysing stories (Horst 2003). 
In the following I will use the terms ‘stories’ and ‘articulations’ interchangeably 
                                          
1 This sample was created by reading two daily newspapers in a period of 1½ years between 
1997-1999 and collecting all the articles, which were articulating health care related genetic 
knowledge and technology or knowledge production concerning human genetics. 
2 Technical difficulties unfortunately has made it impossible to count the number of articles in 
this preliminary archive, but a guess is that it included almost twice as many articles as finally 
selected, that is, 2500-3000. 
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and the term ‘article’ about the analytical unit of the study. It is also important to 
stress that both news (journalistically written articles) and views (opinion pieces, 
including both letters to the editor, longer analyses and editorials) have been 
included in the analysis. Although it is interesting to notice if there is any 
differences in the two types of articles they are basically both part of the mass 
mediated coverage of biotechnology. It should be clear that the objective of this 
analysis is not as much to analyse journalistic practices as to observe the 
outcome in the form of a mass mediated landscape of ‘red’ biotechnology. 
  
For practical reasons I have had to limit the number of media included in the 
search process, but it was important that the chosen media represent a fairly 
broad spectrum in order to give the analysis a reasonable amount of generality. 
Unfortunately, I had to leave electronic media out, since the search process 
within these media would have been too extensive. This is the case for TV and 
radio, where it is very time consuming to search systematically for coverage of 
particular issues in Denmark. A slightly different argument pertains to the 
Internet, where it is relatively easy to search, but where it is extremely difficult 
to know what archive one is actually searching in. On this background I have 
chosen to study the written media, and specifically national newspapers.3 
Focusing on newspapers furthermore has another advantage, since in a Danish 
context it is the type of media, which most clearly has a distinct editorial style. 
This means that it is possible to make some informed choices on which media to 
choose, since I also had to limit the number of written media.  
 
The choice fell on four (initially five) national newspapers of different character. 
These are the two large broadsheets, the social-liberal Politiken and the 
conservative-liberal Jyllandsposten. The third large broadsheet in Denmark 
Berlingske Tidende has been left out because the editorial style of Berlingske 
Tidende, with regard to new technology, was thought to be relatively close to 
that of Jyllandsposten. In order to broaden the analysis two other newspapers 
have been included: The tabloid Ekstra Bladet, and the intellectual niche 
newspaper Information. Ekstra Bladet has a general reputation of being populist 
as well as the most radical tabloid in Denmark. On the contrary Information has 
a reputation of being elitist, left wing oriented and focused on environmental 
                                          
3 A study of the food chains in the Danish media supports this method, since it was shown, 
that electronic media to a very large degree replicate news stories from the printed media 
(Lund 2000).  
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issues. A fifth newspaper, Aktuelt was included at the beginning, but it went in 
during the period under analysis (spring 2001) and has therefore been excluded 
from the set of data.4 Two other smaller national newspapers could have been 
included, but has been left out. This is the business paper Børsen and the 
Christian democratic paper Kristeligt Dagblad. With regard to the business 
angle it should be noted, that Jyllandsposten has quite an extensive business 
coverage and I will argue, that this make up for the exclusion of Børsen. It is 
perhaps more problematic that Kristeligt Dagblad is left out, because it does 
intend to have a distinct editorial style. On the other hand criticism of 
biotechnology inspired by Christian views also do appear in the other 
newspapers and is therefore not excluded from the analysis. 
 
The four newspapers were searched electronically for a period of 4½ years 
(august 1997 to December 2001), and all articles, which contained at least one 
of the keywords in the list, were collected. Since a lot of these articles only 
made very sporadic references to ‘red’ biotechnology they were subsequently 
screened according to the above-mentioned criteria, where genetic knowledge or 
technology should be health care related and also the focus of at least a separate 
paragraph. As mentioned previously, articulation of biotechnology did not have 
to be the main story, but it should be the object of more than one sentence for 
the article to be included in the data set. Articles, which were primarily 
concerned with ‘green’ biotechnology, were also screened out. The result was a 
set of 1575 articles, which function as the central set of data in the following 
analysis.  
 
Table 1 describes the contributions to this archive with respect to each 
newspaper. It appears that Politiken is the newspaper, which has articulated the 
subject of biotechnology in most articles. Jyllandsposten is quite similar to 
Politiken apart from the fact that the issue is covered less often and rarely in 
editorials. Information articulates the issue quite extensively, considering that 
this newspaper has fewer daily pages. Here the issue is often articulated in 
editorials and long news articles, and it also seems that Information has a higher 
amount of views compared to news than the other papers. It should be noted that 
                                          
4 A preliminary analysis of the first three years of coverage, however, indicated that the 
coverage in Aktuelt were very close to the average of all papers in most variables observed. I 
have taken this to indicate that no particular editorial style is disregarded with the exclusion of 
Aktuelt. 
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a large proportion of the articulation of biotechnology in Information is health 
care related and also that the coverage sees to be much more sceptical than the 
coverage in the other papers. In contrast Ekstra Bladet has the almost opposite 
profile. It is more rarely articulated in general, and especially health care related 
biotechnology is not offered very much attention compared to other areas of 
application (primarily forensic uses). Generally it is seldom covered in the front 
page, in editorials and also comparatively more seldom in views. 
 
Table 1 Politiken Jyllandsposte
n 
Information Ekstra Bladet
N 629 446 317 183 
Front page articles 6% 5% 7% 1% 
News 74% 79% 68% 71% 
Large news articles* 29% 32% 43% 37% 
Views** 19% 18% 24% 12% 
Editorials 4% 1% 5% 2% 
Not health care related*** 23% 24% 15% 57% 
Negative towards 
biotechnology 
24% 16% 37% 16% 
*Articles, which in computer print were longer than one A4 page 
**The reason news and views do not sum up to 100% is because there was a third category of reviews and 
announcements 
*** Articles, where human genetics were not linked to health care, but rather to forensic or other issues. 
 
Coding of content 
The objective is to identify patterns in the associations created in articles 
concerning biotechnology, and furthermore to see, which of these stories are 
described as controversial. This includes two analytical operations. First the 
construction of a general map of the associations created in the mediated 
articulation. In this connection the following research questions have been seen 
as relevant: 
  
• What type of biotechnology is discussed? 
• What stages in techno-scientific development is in focus? 
• What are the problems, which biotechnology is articulated as relieving? 
• What is the geographic origin of the occurrence(s) articulated as news? 
• Which human actors are presented in the article? 
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The second step is to explore the question of controversy. It is obvious that 
controversy is a highly fluctuating concept. How should controversy be 
evaluated? According to media sociology, it can be argued that controversy in 
itself is an important feature in the articulation of occurrences as newsworthy 
stories. Therefore a high amount of mass mediated attention towards certain 
issues is a mark of controversy. Controversy, however, is probably not the only 
reason for mass mediated articulation of ‘red’ biotechnology, and I have 
therefore chosen to define controversy more explicitly as disagreement between 
definitions of problems and solutions. When an issue is controversial there is no 
unanimous articulation of definitions of problems and solutions.  
 
By exploring how biotechnology is presented in terms of problems and solutions 
it is therefore possible to establish a kind of measurement for controversy. Since 
the default interpretation of a technology is most commonly to articulate it as a 
solution, the analysis of controversy can focus on how much a technology is 
described as a problem: The more a particular application of genetic knowledge 
or technology is problematised and articulated as a problem in itself, the higher 
the amount of controversy. The operational definition of this measure has been 
to ask:  
 
• Is the main articulation of biotechnology in each article positive or negative?  
 
From these research questions I constructed a code scheme with 6 variables. In 
order to improve reliability I have constructed each question with a fixed set of 
answer categories as shown in the code scheme in appendix A. The variables 
and answer categories were selected on the basis of a number of pilot studies on 
small sections on the material. Following the inductive ambition presented in the 
beginning, the code scheme is therefore not a generic analytical tool constructed 
without connection to the actual data material. On the contrary the construction 
of the scheme has been an integrated part of the analytical work. The questions 
it poses to the individual article should be seen as a generalisation of 
comparisons between the articles. This relational construction of the code 
scheme also means that the categories I have chosen for the different variables 
do not imply to be universal or completely congruent to a knowledge base (e.g. 
medical science) outside the material. When I classify problems to be solved by 
biotechnology in different groups of diseases it is on a basis of what makes 
sense when looking at the articles – not what is correct when looking at the 
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medical classification of disease. Thus, I have a category called ‘Traditionally 
known inheritable diseases’, which is not a proper medical classification, just as 
it cannot be unequivocally distinguished from other groups for instance the one 
called Obesity and metabolic disorders. These categories have grown out of an 
observation in the pilot study, that the articles themselves make these 
distinctions. Sometimes they articulate inheritable diseases as a particular group 
of diseases and sometimes they speak of metabolic disorders. It might to a 
certain extent be the same diseases they refer to, but this is not always the case.  
 
Here we touch upon a fundamental characteristic of the following investigation. 
The object of study is the mass mediated articulations in their positivity. This 
means that I do not see these articulations as representations that can be 
compared to other - more true or real – representations in other social domains. 
All the categories represented in the code scheme reflect real constructions in 
the media – but the categories do not necessarily imply any intrinsic quality of 
realness outside the mediated realms. On this basis the analysis is committed to 
validity claims of internal consistency, coherence and intersubjectivity, but not 
of measurement in relation to any ‘objective’ knowledge base. As far as the code 
scheme goes this means that the arguments for constructing the code scheme in 
the particular way should be transparent and convincing. It also means that 
given the particular construction of the code scheme any observer would classify 
articles in the same categories. I have chosen to deal with all these questions of 
validity in a process of constant communicative validation (Kvale 1994:239). 
Two students have helped me code the articles and we have had a constant 
dialogue on interpretations, kept a log on decisions and so on. The main reason 
for choosing this method of validation is precisely the fundamental assumption 
that the scheme itself is as much an outcome of the analysis as the figures of 
frequency.  
 
Introduction to analysis 
The analysis covers a total of 1575 articles. As it appears from table 1 not all of 
these articulated health care related biotechnology. Altogether 405 articles are 
primarily occupied with other uses of biotechnology, primarily genetic testing in 
the judicial system. I have chosen as a general rule to disregard these articles. 
Although they articulate the same types of technology – primarily the genetic 
test – it proved to be difficult to use the same variables as with the health care 
related stories. Where nothing else is mentioned the following analysis is based 
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on the 1170 articles that are concerned with health care related problems and 
solutions. 
 
It should be mentioned that the following is a description of the kind of 
associations that are most frequent in terms of number of articles. The relevance 
of this measure can be discussed since the articles can vary according to their 
length and editorial placement. On this background I have included some 
editorial categories in order to elaborate on the very one-dimensional 
measurement of number of articles. When it is considered a contribution, I 
therefore include two other variables. First of all, I have looked at the placement 
in the paper. Placing a news story on the front page indicates top-priority, 
whereas placement in later sections indicates lower priority or communication to 
special segments. Secondly, I have sometimes distinguished between journalistic 
articles and opinion pieces. Most important, however, is it to be constantly 
aware that the analysis measures associations in articles, but this does not reveal 
anything about causal explanations. From this analysis it is only possible to 
observe associations in the form of co-variance, not in the form of dependent 
and independent variables. Therefore, the tables and figures of frequency in the 
following have been designed to be easy to read, not to document causal 
explanations. 
 
The analysis is structured in three parts. The first is a general description of 
associations between phenomena in the articles: which kinds of technological 
applications, health problems and techno-scientific stages are presented in the 
articles? The second part deals with the association of sources to the other 
phenomena, and tries to answer whether there are distinct patterns in the way 
different actors are associated as sources to different phenomena. The third part 
of the analysis is concerned with the question of controversy and investigates 
whether particular problems, techno-scientific applications, techno-scientific 
stages and actors are particularly articulated as controversial.  
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What are the newsworthy issues 
This section is an effort to characterise the newsworthy issues in the articulation 
of biotechnology. During the pilot studies, four variables were constructed that 
could provide an overview of this:   
 
• Applications of biotechnology 
• Stages in the techno-scientific development of a technology 
• Articulation of problems to be solved by biotechnology 
• Geographic origin of occurrence to be treated as news 
 
Applications of biotechnology 
Biotechnology can be seen as a broad field of practices covering many distinct 
technologies, techniques or fields of applications. Rather than trying to define 
these different technologies according to some technical criteria, I have let the 
way the articulations construct distinct fields of application be the main 
categories. Thus I have identified 8 different applications that seemed to be 
articulated as distinct from each other in the articles. 
 
Figure 2: Applications of biotechnoogy
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It should be noticed in figure 2 that the fields of application are not mutually 
exclusive since an article can easily cover more than one of these fields. As the 
figure shows, the eight applications are articulated with different frequencies. 
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This is not remarkable in itself since the eight categories do not imply any kind 
of even distribution. It is, however, obvious that those fields of application, 
which generally can be said to be at a more preliminary research stadium (such 
as gene therapy and human cloning), are covered relatively more often than 
applications which are further developed in terms of concrete use (such as 
reproductive technologies, genetic tests and genetics in pharmaceutical research 
and production). Revolutionary or far-reaching uses of biotechnology thus 
receive most attention. The articulation of the eight types of application also 
differs in other aspects and I have tried to summarise the main findings in table 
3. 
 
Table 3: Characteristics of coverage of different fields of application 
 
Average monthly
Coverage 
Standard 
Deviation/month
Frontpage 
rate 
Single-issue 
rate 
Humane Cloning 6,4 9,5 3% 47% 
Humane Genome Mapping 6 3,8 4% 39% 
Animal Experiments 5,1 4,4 3% 19% 
Humane Gene Therapy 4,9 7 7% 54% 
Prenatal Tests 4,3 3,3 8% 46% 
Postnatal Tests 3,3 2,2 5% 21% 
Other reproductive technologies 2,7 2 3% 27% 
Pharmaceutical production 2,1 2 3% 11% 
 
The first column in table 3 is an indication of the number of articles covering the 
particular application each month. The second column is an expression of the 
intensity in articulation over time. A large standard deviation indicates big 
differences in attention between different months and thus it serves as an 
indication that the application in question has been articulated in concrete case 
stories receiving much attention at some points in time. This is the case with 
cloning and gene therapy. On the other hand a small deviation indicates, that the 
articulation is much more stable. The next column is an indication of perceived 
importance, as putting an article on the front-page signals high priority. It 
appears that genetic tests (especially prenatal) and human gene therapy are fields 
of application, which most often has been presented as important in this way, 
but the differences are relatively small.  
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Finally the last column is a result of the fact that articles often articulate more 
than one of the fields of application, and it has been a methodological choice to 
reflect this inclusion in the coding practice. On this background the last column 
indicates how often any field of application is articulated as the single issue in 
an article. This measure indicates whether a field of application seems to be a 
newsworthy article in itself or whether it is most often combined with other 
fields of application. In this connection it is noticeable that all applications 
routinely are presented together with each other. Gene therapy is the application, 
which most often stands alone, but still it is associated to other fields of 
application in nearly half the articles. In the following paragraphs I will present 
the main characteristics of the articulation of the different fields of application. 
In addition to table 3, these descriptions also draw upon Figures A1-A8 
(Monthly frequency of each application) and table B (Frequency in 
combinations between fields of application), see appendix B. Furthermore I have 
observed the headlines of the concrete articles in each group. 
  
Human cloning is the most intensely articulated application, although it is not 
often on the high priority front pages. As mentioned the differences in time are 
big and concentrated around three periods. I have elsewhere provided a detailed 
account of the articulation of cloning. Generally it should be noticed that 
although it is relatively high on the agenda, it is seldom front-page news. 
Furthermore it appears from table B that when cloning is associated with other 
fields of application it is most often animal experiments. This is primarily 
because Dolly the sheep plays an important role in the discussions of human 
cloning. 
 
Genome mapping is used about articles, which specifically articulate the human 
genome project, but also other articles, which present new discoveries of genes 
or mutations. This field of application receives a lot of attention that is quite 
evenly distributed. The table also reveals that genome mapping is relatively 
often covered as the single issue. From table B in appendix B it appears that 
when it is associated with other fields of application these are most often 
postnatal testing and pharmaceutical use, but the patterns of association with 
other applications are inclusive so that most combinations occur. Altogether this 
suggests that genome mapping is articulated in a continuous stream in the mass 
media. It never receives extremely high amounts of attention but the issue of 
genome mapping is articulated in many different contexts.  
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The total number of articles about genome mapping is 318, of which three out of 
five articulate it as the single field of application. Many of the stories 
concentrate on general issues concerning the project of genome mapping, but the 
sample also include articles that present new knowledge about particular genes 
and diseases or human characteristics: “Gene for speech problems found”, 
Happiness is genetically determined”, “Gene for dyslexia found” “A gene for 
baldness”, “Gene can cause asthma”, “Gene regulates the good cholesterol”.5 
These presentations could be taken to indicate a kind of genetic determinism6, 
but it must be considered that headlines can have a sharper edge than the rest of 
the article and furthermore other headlines seem to point in the reverse direction: 
“Man is more than genes”, “Two descriptions are better than one”, “The 
ambiguity of genes”, “Do alcoholic genes exist”[!] and “Tracking the gene for 
Gucci-boots”.7 Besides these kinds of articles that primarily deal with genetic 
knowledge as a code, which holds some kind of information about the 
phenotype of humans, there are also articles that seem to be more concerned 
with the status of genetic knowledge as an economic resource that should not be 
taken undue advantage of: “Genetic register sold abroad”, “Fear of monopoly on 
genes”, “Gene trade raises concern” and “Easy game for bio-pirates of the rich 
world”.8 Also questions concerning new legislation on patents on 
biotechnological innovations fall in this category of genetic knowledge as a 
resource that should be treated properly.  
 
The category animal experiments is used about articles, where animal 
experiments are articulated as relevant for the purpose of learning about the 
human genome and health care related genetics. It does not include animal 
experiments presented as having only agricultural purposes. The articulation of 
this field of application is very similar to that of cloning. As mentioned above 
                                          
5 Politiken 23 February 1998, Politiken 10 June 1998, Politiken 13 September 1999, Ekstra 
Bladet 6 July 2001, Jyllandsposten 26 June 1998 and Jyllandsposten 16 August 1999 
respectively. 
6 The amount of genetic determinism in newspaper coverage has been object of several 
studies (Condit 1999; Nelkin & Lindee 1995). Conclusions of these studies are contradictory 
and seem to indicate that the findings depend on the analytical perspective. 
7 Politiken 19 February 1998, Politiken 27 June 1999, Politiken 15 January 2000, 
Jyllandsposten 19 October 1998 and Information 28 February 1998 respectively 
8 Politiken 26 July 1998, Politiken 26 July 1998, Jyllandsposten 29 January 1999 and 
Information 12 January 1998 respectively. 
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this is not strange since they are very often articulated in the same articles (45% 
of the articles on animal experiments also treat human cloning, table B). 
Furthermore, although the distribution of articles about animal experiments is 
more equal between months than that of cloning, it still follows more or less the 
same pattern (high attention in the same months – figure A1 and A3 in appendix 
B). Compared to human cloning, however, animal experiments are not very 
often the single issue in an article. On this background it seems that animal 
experiments in this selection of articles is not articulated as a newsworthy issue 
in itself, but it is quite often articulated as a part of stories about human cloning. 
When the issue of animal experiments is articulated on its own, it seems that 
research on a wide range of animals can provide useful knowledge: “Worm 
explains sexual needs”,  “About primeval genes in green flies”, “Gene made 
mice faithful”, “Mammoth cloning”, “Calves cloned from breast milk” and 
“Mapping pigs genome” 9. As it appears from these quotes, it seems that animal 
cloning and identification of genes is articulated as the two major areas where 
research on animals can benefit research in health care related biotechnology.  
 
The high amount of articles about gene therapy is connected to one particular 
case in Århus beginning in July 1999. This case evolved around a research 
project on gene therapy against liver cancer and it is analysed in depth elsewhere 
(Horst 2003). Here it should be noted, however, that more than a third of the 
articles about gene therapy concentrate on this case. This is probably the reason 
for the relatively high amount of front-page stories and the high amount of 
articles articulating only gene therapy (highest single-issue rate). On the other 
hand, when gene therapy is associated to other fields of application, it seems that 
gene therapy can be combined with all the other types of application, as none 
stand out as particularly common (table B in appendix B). Had it not been for 
this particular case, the articulation of gene therapy might have resembled that 
of pharmaceutical production, which I will shortly return to as a field of 
application, which occasionally is articulated as a single issue in specific stories, 
but elsewhere is articulated as a part of the general development within 
biotechnology. 
 
                                          
9 Politiken 27 September 1999,  Information 22 December 1997, Politiken, 23 August 1999, 
Ekstra Bladet 24 January 1999, Jyllandsposten 27 April 1999 and Politiken 29 June 2000 
respectively. 
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Taken together prenatal and postnatal genetic tests are the most commonly 
articulated field of application (31%). I have chosen to separate the two kinds of 
tests, since they seem to generate different kinds of articulations. As a starting 
point it is only every fifth of the articles, which covers both kinds of tests. 
Furthermore, they are presented differently, as I will try to show in the 
following. 
  
Of all the fields of application prenatal tests are the most likely to appear on the 
front page. At the same time articles about prenatal tests are relatively evenly 
distributed and they are also relatively often the single issue in an article. On this 
background it seems that although there are no spectacular case stories about 
prenatal tests it is a type of application, which create stories in its own right. 
This is interesting because prenatal tests have been a standard service in the 
Danish health care sector for more than 20 years. This observation therefore 
means, that familiarity with a technology does not necessarily mean decreasing 
mass mediated articulation.  
 
A quick look at the headlines from articles about prenatal tests, show that stories 
focus on both the concrete service and the more abstract societal consequences 
of this practise. Some articles focus on technical aspects of the service: “Blood 
test can reveal risk of handicap”, “Scanning: Differences in service to pregnant 
women” and “Foetus counselling should be improved”10. Other focus on future 
possibilities: “Choose yourself: Boy or a girl” and “Free trade in foetus 
control”11. There are however, also a large group which discuss the basic logic 
behind prenatal tests: “”No to a selective society”, “On the road to eugenics”, 
“Should I have been an abortion” and “Help to children with Down’s syndrome 
instead of testing pregnant women”12. If we combine the impression from these 
headlines with the observation from table B that prenatal tests most often is 
associated with other reproductive technologies a pattern emerges. It seems, that 
prenatal tests is often discussed as an application that allows for selecting (or 
designing) babies. Similarly it appears to be closely connected to the issue of 
abortion, whereas treatment or preventive measures are not so often thematised. 
                                          
10 Jyllandsposten 13 February 1998, Politiken 17 April 2001 and Information 26 August 
1998. 
11 Jyllandsposten 6 July 2001 and Information 28 March 1998. 
12 Jyllandsposten 14 July 2001, Information 22 August 1997, Ekstra Bladet 13 May 2001 and 
Politiken 20 August 1999. 
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Postnatal tests on the other hand, seems to be represented very differently. They 
are rarely articulated as the only issue in an article, and most common is that it is 
associated with genome mapping (42%, table B). Articles about this issue are 
evenly distributed with no spectacular cases, but contrary to representations of 
prenatal tests, the focus in these stories seem to be on future possibilities of 
testing humans for diagnostic, preventive or even therapeutic reasons. Some of 
the stories focus on single genes or disorders like “Cancer risk can be revealed 
by spit test”, “Can I see your crime genes” and “Bad hearing is seen in blood”13. 
Other articles focus on genetic knowledge about an individual in general: 
“”DNA chips depict your constitution”, “The crystal ball of the future”, “Get 
your own personal DNA profile” and “Know yourself – know your genes”14. As 
also discussed in connection to the stories about human genome mapping the 
most striking feature is the essentialism ascribed to genes. It seems that in the 
genes, we can find determinate answers about the future, so the tests is presented 
as the crucial point of no return. Get the test and your destiny will be disclosed.  
 
Many of these representations also seem to imply that this new knowledge can 
be troublesome: “Gene test and future anxiety”, “Straining knowledge about 
genes” and “Genome: Oracle or Nemesis”15 and some go so far as to issue 
warnings against tests: “The ethical council warns against mail order tests” and 
“Warning against cancer gene test”16 Contrary to the case of prenatal tests, 
however, these warnings seem to be related to the individual herself. It is the 
troubling situation of knowing about ones own future that is at stake here, not so 
much the consequences for society in general. If compared to prenatal tests it 
seems that postnatal tests are primarily presented as newsworthy because of 
their prospects as an application designed for individual consumption. Warnings 
are primarily issued as consumer guidance, where warnings against prenatal 
tests more often take the shape of general resistance (against eugenics and 
abortion).  
 
                                          
13 Politiken 20 March 2000, Information 5 March 2001 and Politiken 8 March 1999. 
14 Politiken 4 November 1999, Information 21 December 1998, Jyllandsposten 8 May 2000 
and Jyllandsposten 11 April 2000. 
15 Politiken 31 March 2001, Jyllandsposten 29 September 2000 and Information 19 March 
2001. 
16 Politiken 27 July 1998 and Jyllandsposten 3 March 2001. 
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It seems relevant in this connection to make some brief comparisons with the 
large amount of newspaper articles that does not treat human genetics in 
connection to health care related issues. This is relevant, because the large 
majority of these articles focus on the forensic use of genetic tests.17 Especially 
two issues have been treated as controversial: widening the access to DNA-
testing of fatherhood and the construction of a national register of DNA profiles 
from criminal suspects. It is interesting that these forensic uses apparently give 
rise to issues of a more general and collective nature, than health care related 
genetic tests that primarily focus on issues concerning individual consumer 
problems. In contrast, proponents of the forensic use of genetic tests stress the 
benefits for society as such, but also the opponents often refer to general social 
developments: “Grotesque snooping” “Give us back a state of justice” and 
“Lawyer calls DNA test pure Gestapo”18. In short these differences between the 
articulation of different uses of genetic tests seem to indicate that prenatal tests 
are primarily controversial because of their linkage to eugenics and selection, 
postnatal tests in the health care system are primarily covered as a technology 
for individual consumption and postnatal tests outside the health care system are 
primarily controversial with regards to the protection of privacy in a 
constitutional state.  
 
The category of Other reproductive technologies refers to the fact that human 
cloning and prenatal tests are treated as two special cases. Articles, which fall in 
this category, therefore mention other applications of biotechnology in 
connection with fertility and pregnancy: IVF, micro-insemination, sperm 
donation, and pre-implantation diagnostics. In this category I have also included 
general descriptions of designing or engineering babies. It is possible, that this 
status as a residual category has consequences for the outcome. In any case it is 
not very distinct compared to the other fields of application with regard to any of 
the quantitative measures. It is relatively seldom articulated as single issue. Not 
surprisingly it often appears in association with prenatal tests and human 
cloning, but also gene therapy is often mentioned together with reproductive 
technologies. Some of these articles focus on new possibilities in fertility 
treatment, but looking at the headlines, it seems that the idea of artificially 
                                          
17 When human genetics is discussed without reference to health care problems it is almost 
exclusively in connection to forensic uses of genetic tests.  
18 Jyllandsposten 28 January 2000, Ekstra Bladet 3 November 1999 and Information 9 June 
1998. 
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creating babies generally is a hot issue: “Designer babies: genes for sale”, “The 
man made man” and “Short-cut [genvej, MH] to the perfect human being.”19 It 
is interesting, that there also seems to be a certain freak appeal in the 
articulations: “Baby with three parents”, “Experiment with babies”, “Parents 
demand super seed” and “Eggs can be fertilized without sperm”20 Thus it seems 
like the articulation of reproductive technologies primarily are preoccupied with 
the possibility of designing babies, but these creations are presented with a 
mixture of fascination and horror.  
 
Finally the term pharmaceutical uses of biotechnology designates both the 
production and the utilization of pharmaceuticals. As figure 2 indicates this is 
not a very prominent field of application in the mediated articulations. It rarely 
figures on the front page and the coverage does not seem to be dominated by 
any particular case stories, as it is evenly distributed between months. Only 
every tenth article covering pharmaceutical uses is it the single issue, and this 
implies that it does not have a high news value in itself. In stead it is often 
associated with either animal experiments or genome mapping. Business angles 
are relatively frequent in the articulation of this technology, and the framing 
seems to be rather positive within the time-span of the present analysis: “Fusion 
generates money for research”, “Biochip can become gold” and “Gene break-
through turn technology shares to gold.”21 
 
Summarising it seems that revolutionary or far-reaching uses of biotechnology 
receive most attention, but familiarity with a field of application does not 
necessarily lead to decreasing interest. Some of the applications, like cloning 
and gene therapy, are articulated in spectacular case stories, leading to a very 
uneven distribution of the attention between months. The articulation of these 
two types of application is analysed in Horst (2003). In contrast, other types of 
application, such as genome mapping and genetic tests, seem to receive attention 
on a much more stable basis. For instance, genome mapping is articulated in a 
continuous stream in the mass media. It never receives extremely high amounts 
of attention but the issue is articulated in many different contexts and in 
                                          
19 Politiken 5 December 1999, Information 26 November 1999 and Jyllandsposten 27 
September 1998. 
20 Politiken 2 August 2001, Information 9 April 1999, Jyllandsposten 9 April 2001 and 
Politiken 12 July 2001. 
21 Jyllandsposten 1 February 2000, Jyllandsposten 13 November 2001 and Jyllandsposten 28 
June 2000. 
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association to most of the other fields of application. Also genetic tests are 
frequently articulated, and it appeared sensible to distinguish between the 
articulation of prenatal, postnatal and forensic tests. Whereas prenatal tests were 
primarily articulated as controversial because of their linkage to eugenics and 
selection, forensic tests were controversial with regards to the protection of 
privacy in a constitutional state. In contrast to this, postnatal tests were primarily 
articulated as a technology for individual consumption.  
 
Stages in the techno-scientific development of a technology 
The term technoscience has been adopted to avoid an a priori distinction 
between technology and science. Nevertheless, it is possible to question whether 
the media articulate stages in research and development of technology and 
whether there are differences between these articulations. On the basis of the 
pilot studies it seemed relevant to operate with a threefold division between 
basic research, applied research, and routine use.22 On top of this, two other 
categories where needed as one kind of articles dealt explicitly with regulatory 
aspects and another group articulated general background information often 
incorporating all of the above-mentioned stages.  
 
It should again be noticed, that the categories in no way claims to be a 
description of research and technology as it takes place in laboratories and 
research institutions, where the distinction between for instance basic and 
applied research can be quite difficult to uphold. In the context of media 
analysis, however, it turned out to be a reasonable way of categorising the 
mediated articulations. The categories have been described so that basic 
research is used about presentations of new knowledge and discoveries within 
biotechnology, which is not directly linked to the solution of a concrete problem. 
Altogether 25 % of the articles have this primary focus. Of these two thirds 
focus on specific new discoveries of genes, mutations or technologies, whereas 
the last third are general descriptions of advances in basic genetic research. 
Applied research on the other hand is used about the articulation of 
biotechnology, which explicitly is addressed to solving a concrete problem, e.g. 
new therapy, diagnostic tool, or new reproductive technology. Approximately 23 
% of all articles present this type of applied research.  
                                          
22 The coding was designed, however, to make it possible to distinguish between 2 kinds of 
reporting basic research. The first is the articulation of new discoveries of genes or 
techniques, and the second is articulation of basic genetic research in general. 
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Whereas the stories of basic and applied research all have some sort of novel 
knowledge, technology or technological use as its core focus, another 27% 
primarily articulate routine use of biotechnology. An example could be an 
article about the fact that the use of amniocentesis is declining, accompanied by 
discussions of possible reasons behind this decline. Furthermore, 20% of the 
total sum of articles focuses on issues of public regulation, and this is both in 
connection to discussions about the use of specific technologies – gene therapy, 
foetal diagnostics – but also in relation to regulation of specific forms of praxis 
in the research community – research on embryos, patenting genes and so on. 
Finally the focus in the remaining 5 % has been termed background, as these 
articles can be seen as general updates on the techno-scientific development. 
From this, it is obvious that seen as a whole, all four of these distinct techno-
scientific ‘stages’ receive attention.  
 
Figure 4: Fields of application and techno-
scientific stages
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Figure 4. Techno-scientific focus of articles which only cover one field of application,  
N=668. It should be noted, that the lowest N is found in Pharmaceutical use (n = 12) and Postnatal test (n=37) 
 
When we look at the fields of application separately, however, large differences 
become obvious. In figure 4, I have excluded all articles, which cover more than 
one technology so as to present the differences between the coverage of the 
individual technologies more clearly. 
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From figure 4 it appears that applications like Human genome mapping, Animal 
experiments, Gene therapy and Pharmaceutical use are very often associated to a 
prime focus on research aspects. Of these, gene therapy is primarily articulated 
as an object of applied research, e.g. as research conducted with a specific aim 
of treating a particular problem. The other three are most often articulated as 
objects of basic research. Thus judging from the mediated coverage it would 
seem, that gene therapy is further advanced in the direction of concrete 
applications, than for instance pharmaceutical uses. Furthermore figure 4 reveals 
that genetic tests (both prenatal and postnatal) and reproductive technologies are 
rarely articulated with the primary focus on research. Instead they are more 
often associated to routine use and/or public regulation. Finally the issue of 
cloning stands out as the field of application most often covered with the prime 
focus on public regulation.  
 
It might be viewed as strange that a prime focus on routine use is also found in 
some articles concerned with human cloning and gene therapy, although these 
technologies are not yet implemented in any routine use. This can be explained 
by the fact that newspaper articles (especially more polemical viewpoints) 
sometimes use the rhetorical technique of describing the anticipated 
development, as was it already real. Sometimes it is obvious from the way the 
argument is put, that it is a future vision, but at other times it is quite hard to 
decide on the basis of the newspaper article, whether human gene therapy for 
instance is presently a working therapy. Following the general analytical 
strategy of mapping the mass mediated stories as they present themselves, 
human cloning has been coded as routine use if it is presented like this – no 
matter that no laboratory has yet officially presented it as such. 
 
Newsworthy problems 
Health care related biotechnology is primarily described as solutions to health 
care related problems such as different kinds of diseases as shown in figure 5. 
Again it should be noticed that although they bear some resemblance to official 
categories of diseases, the taxonomy does not claim to be correct, as a medical 
classification. The category of traditionally known inheritable diseases covers 
the long list of different kinds of diseases which have been known to be 
inheritable or congenital and therefore traditionally an object of medical 
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genetics.23 Furthermore the groups of diseases have been supplemented with the 
category of normality as it turned out, that many of the articles are concerned 
with genetic dispositions for intelligence, hair colour, weight, psychological 
characteristics and so forth.  
 
As figure 5 shows, Inheritable diseases is still widely articulated as a problem to 
be solved by biotechnology, but almost as much attention is devoted to issues of 
normality and reproduction. Whether the amount of interest devoted to issues 
concerning normality is high or low (around 16%) depends on the perspective, 
but it is fair to say that issues of normality are receiving more attention than 
most of the disease groups. On the other hand, taken as a whole the problems 
articulated to be solved by biotechnology is primarily diseases of various kinds 
as altogether 67% of the total number of articles associate to at least one of these 
disease groups. 
 
                                          
23 As example chromosome deviations like Down’s syndrome, monogenetic dominant 
diseases like Huntingdon’s Chorea, monogenetic recessive diseases like cystic fibrosis, as 
well as deformities typically discovered by ultrasound scanning of foetuses. Practically the 
category has been defined by a list constructed on the basis of a medical compendium. 
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Figure 5: Problems to be solved 
by genetic techno-science
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Cancer seems to be the dominating problem, as every fourth of the articles is 
associated to cancer. The spectacular case about gene therapy to liver cancer 
patients has some part in this high figure, but it must still be considered as 
remarkable. Especially when compared to the other major disease groups like 
heart diseases, diabetes, rheumatism, and allergies it is obvious that cancer has a 
special status. Considering these other groups of diseases, it is interesting that 
neurology and dementia receives relatively much attention – and it can be added 
that in particular this attention is given to Alzheimer’s disease. On the other 
hand Astma/allergies as well as Obesity are not problems that seem to take up 
much mediated space in connection to biotechnology. 
 
It can be observed that all the disease groups, which are not articulated very 
often, are also seldom the single issue in an article. It seems that none of these 
disease groups are able to generate newsworthy stories in themselves, but as a 
general field of problems to be solved by biotechnology they do receive 
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attention. Cancer on the other hand, is apparently a story in it self, as more than 
half of the stories on cancer only focus on this problem. 
 
Seen in relation to specific fields of applications, some interesting patterns can 
be observed in table C (appendix B), as some fields of application is primarily 
associated to particular disease groups. For instance Traditionally known 
inheritable diseases are often linked to prenatal tests (57% of articles covering 
inheritable diseases), whereas cancer is linked to gene therapy (52%). From 
mass mediated coverage then, it seems that whereas the perceived chance of 
fighting cancer should be found in gene therapy (as in the case from Århus), 
inheritable diseases should instead be fought by prenatal testing. Reproduction is 
primarily connected to human cloning (61%) which is perhaps not strange since 
cloning can be seen as reproduction. But also neurological diseases are primarily 
linked to cloning (55%) and this is probably due to the increasing interest in 
therapeutic cloning, which is often linked to a cure of Alzheimer. Finally issues 
of normality (51%) as well as psychiatry (77%) are linked to genome mapping. 
A strong interpretation of these figures could be, that in these areas solutions are 
not presented as developed equally far as with the other groups, since genome 
mapping is primarily concentrated on finding genes for particular traits and 
diseases.  
 
Summarising the mediated articulation of problems, cancer is a dominating 
theme, and associated to a cure by gene therapy. Inheritable diseases are also 
still a major issue and should be avoided by prenatal testing. Human cloning, on 
the other hand, is associated to reproductive problems and neurological diseases, 
both of which are also of relative importance. The other groups of diseases are 
rarely articulated as single issues and there is not a single field of application 
that seems to be the answer to the problems they pose. Psychiatry, though, is 
special, since it seems that there are no solutions to psychiatric problems 
although we might discover the genetic causes. Finally, issues of normality do 
get relatively much attention and is primarily portrayed as a question of 
identifying single genes connected to particular traits and characteristics. 
 
Geographical origin of stories 
As biotechnological research and applications have global implications, mass 
mediated news on these topics possibly originate all over the world. The pilot 
study, however, demonstrated that it would make sense to divide the world in 
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four parts: Denmark, Europe, USA and the rest of the world.24 The most 
noticeable thing is that almost all news articles focus on occurrences in the 
‘western world’. From figure D (Appendix B) it appears that almost two thirds 
of the articles cover stories that originate in Denmark (60%), whereas the rest is 
divided between USA (19%) and Europe (16%) and only 4% from the rest of the 
world. 
 
Figure 6: Geography and tecno-scientific stages
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From figure 6 it is evident that stories from Denmark is relatively less concerned 
with basic research as with applied research and routine use of technologies. 
This tendency can be further clarified in table E (appendix B), where it emerges 
that the Danish stories particularly deal with gene therapy and the routine uses 
of genetic tests and reproductive technologies. Furthermore it appears from table 
F that Danish stories are particularly concerned with Inheritable diseases and 
Cancer, whereas most of the other disease groups receive relatively low 
attention. 
 
Stories from Europe primarily deal with aspects of public regulation, and from 
table E it appears that this is especially in connection with human cloning. This 
is interesting since the time period covered do not include spring 1997, where 
the cloning of Dolly in Scotland was published. Furthermore, animal 
experiments and the general mapping of the human genome are relatively 
                                          
24 It is the geographical origin of the occurrence that is coded. A story about new research in 
USA is coded as USA even though it might contain reactions from Danish researchers. 
Another article that deals solely with Danish reactions is coded as Denmark. 
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common issues in stories from Europe. On the other hand applied research as 
well as routine use do not receive very much attention. Likewise it appears from 
table F that European stories relatively rarely present specific health problems to 
be solved by biotechnology as more than one third do not cover specified 
diseases or problems to be solved.  
 
The stories from USA on the other hand do not deal with regulation. In stead 
they focus primarily on basic research, and from table E it appears that the 
mapping of the human genome is in focus in more than one third of these 
articles. Compared with the Danish and European stories, it can be observed 
from table F that the American stories deal with a lot of different health 
problems, which biotechnology is intended to relieve, for instance cancer, heart 
diseases, diabetes and neurological diseases. The American stories however 
have one thing in common with European stories and that is a comparatively 
high amount of stories that cover biotechnology in relation to normality. This is 
one of the more controversial uses of biotechnology within the health care sector 
and so the mass mediated articulation leaves the impression, that the most far 
reaching consequences of biotechnology is coming from outside Denmark. 
 
Finally, stories from outside Europe and USA only make up 4 per cent of the 
total coverage. These stories cover different aspects of biotechnology, although 
there is comparatively more focus on research than on routine uses and public 
regulation. From table E and F it appears that there is a remarkably large amount 
of the stories that focus on reproductive problems and fields of applications 
related to reproduction (Cloning, reproductive technologies and animal 
experiments). This implies that reproduction seems to be the major problem for 
biotechnology to solve in the rest of the world. 
All together these differences can be interpreted to imply a mass mediated 
picture in which new breakthroughs with extensive consequences primarily 
comes from abroad. Whereas American stories primarily articulate new 
discoveries with far-reaching consequences and possibilities of curing heart-
diseases, cancer, diabetes, neurological diseases and so on, European stories are 
much more concerned with issues for regulation, particularly in connection to 
human cloning. In contrast, the domestic research front is portrayed as primarily 
occupied with concrete uses of knowledge and technology in diagnose and 
therapy. With the exception of gene therapy as a cure for cancer, Danish news is 
not so concentrated on revolutionary research, but focus considerably more on 
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the concrete and practical implications of genetic tests and reproductive 
technologies in the daily life of ordinary people. 
 
 
The articulation of human actors 
This part investigates what kind of human actors that appears in the stories about 
biotechnology. The basic assumption is that actors are articulated in different 
roles by being inscribed in the network of articulation. It is the productive work 
of the mediating practice to articulate the actors in these roles, for instance as 
genetic researcher or politician. A human actor is articulated as an actor in so far 
as he is presented in a particular role as performing actor. This should not be 
taken to imply that there is no connection to actual living persons by the same 
names as the actors articulated in the article. Rather it is used to emphasise that 
they are shaped, created or negotiated by journalistic work. It is the practice of 
exploring the network of articulation that lead to the articulation of actors in 
certain ways.  
 
In this context, it should also be emphasised that it is the mediated articulation 
of an actor that is the object of the analysis. A member of the Ethical Council is 
only counted as such, if he is explicitly presented this way in the article. Just like 
researchers are actors, which is presented as researchers in the concrete article. I 
am not trying to measure how often the ethical council or its members get 
through with a message in the media. Rather I am counting how often the 
mediated stories include an actor presented as member of the ethical council. 
The objective of the analysis is to describe the way the mediated stories 
articulate biotechnology, not to study how the mediated articulation fits with an 
outside reality.  
 
Furthermore, observing the mediated articles it is not possible to determine what 
kind of relation the journalist has had to the human person articulated in a role 
as actor. For instance whether the journalist has used the person as direct source 
to the story or whether the relation is more indirect. The analysis is therefore not 
designed to make distinctions between, for instance, sources and other kinds of 
actors in the articles. Rather, the articles are taken at face value and all the actors 
presented are included no matter whether they are cited directly, indirectly or in 
other ways recognised as actors. 
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Figure 7: Frequency of actor groups
0%
10%
20%
30%
40%
50%
60%
70%
Re
se
arc
h a
nd
 he
alt
h c
are
Ci
tiz
en
s a
nd
 pr
ofe
ss
ion
als
Bu
sin
es
s &
 or
ga
nis
ati
on
s
Po
liti
cia
ns
Ad
vis
ori
y c
om
mi
tte
es
Pa
tie
nts
Ad
mi
nis
tra
tio
n
 
 
Again the pilot study was used to design a list of categories of actors that 
seemed appropriate for the analysis of associations. Altogether 20 different 
actor-categories were found and they have been clustered in 7 different groups. 
Acknowledging that most articles present more than one actor, the analysis has 
been designed so as to make it possible to code each article for more than one 
actor category. The categories have furthermore been supplemented with a count 
of the number of actors in each article. 
 
From figure 7 it appears that by far the most common group of actors are 
researchers and health care professionals, as two thirds of the articles include 
this group. Further details are available from table G in appendix B, where it is 
shown that this group is primarily medical researchers and other scientists. 
Danish and international medical and natural scientists each appear in 
approximately one third of the total sum of articles, whereas Danish social 
scientists appear in 8% of the articles. The last group, however, very often 
appear as authors of opinion pieces (Every third article is a opinion piece). 
Finally health care professionals (nurses, midwives and so forth) appear in 6% 
of the articles. On this background it must be concluded that stories about 
biotechnology very often associate to medical and scientific expertise.25 
                                          
25 In this connection it can also be mentioned that scientific journals are cited in 11% of the 
articles (of these are 1% Danish), hereby also stressing a rather widespread use of scientific 
sources. 
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In order to expand the analysis of each group of actors I have inquired into what 
kind of techno-scientific stages as well as fields of technological applications 
they are associated to in the articles. From figure 8 it can be seen, that 
researchers and health care professionals appear a little bit more often in articles 
focusing on basic research, but the distribution is very close to the average. 
From table H in appendix B it can similarly be observed that researchers and 
health care professionals are articulated in association to all the fields of 
application, but relatively rarely in stories about reproductive applications, such 
as cloning, prenatal tests and other reproductive technologies.  
 
The second group of actors is made up of individual persons such as citizens 
(13%), professionals outside the health care sector (10%) and celebrities (6%), 
and this group is articulated in little more than a fourth of the articles. It should 
be noted that more than half of the appearance of ordinary citizens has the form 
of opinion pieces, whereas the other two types mostly appear in news (table G). 
In contrast to the group of researchers it appears from table H that citizens and 
professionals are most often associated to technological applications relevant for 
human reproduction such as cloning, reproductive technologies and prenatal 
tests. Similarly it can be observed from figure 6 that they are often associated to 
routine use of technologies and less often to either basic or applied research. 
Altogether, citizens and professionals are therefore comparatively most often 
articulated in connection to routine use of reproductive applications. 
 
The third group of actors consists of business and organised interests, which 
altogether appear in every fifth of the articles. International firms are most 
common, since they are articulated in 12% of the articles, whereas Danish firms 
only appear in 6% of the articles. Organised interests, such as unions and 
industry organisations appear in 5% or the articles. None of these subgroups are 
very often authors of opinion pieces, but are primarily articulated in 
journalistically written news articles. From table H it can be observed that this 
group of actors primarily are associated to pharmaceutical use of biotechnology 
and from figure 8 it appears that business and organisations relatively more 
often is associated with basic research than other groups. 
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Figure 8: Actors and techno-scientific focus
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Politicians are articulated in almost every fifth article. It appears that Danish 
MP’s (8%) are articulated more often than cabinet members (5%) and they are 
also more frequently authors of opinion pieces. The most frequent political 
actors, however, are international politicians (9%). From figure 8 it emerges that 
public regulation is by far the most common techno-scientific stage for 
politicians to be associated to, and furthermore it can be seen from table H that 
of all the different fields of application, politicians are most frequently 
associated to cloning. 
 
The fifth group is the advisory committees. In Denmark there are three types of 
permanent boards producing advice and other input to the policy process. Of 
these the Council of Ethics and members of this council is by far the most 
frequently articulated actors (9%). The Board of Technology is primarily a body 
for organising participatory processes and other dialogues over science and 
technology – this is probably one reason why this body is only very rarely 
articulated as actors (1%). Finally the system of Research Ethics Committees 
works as authorising bodies in connection to ethical aspects of medical research 
on humans. These committees are cited in 2% of the articles. It can be observed 
that while members of the Council of Ethics relatively often authors opinion 
pieces; the members of the Research Ethical Committees have only done this on 
one single occasion. From figure 8 it appears that just like politicians, these 
advisory bodies primarily appear in articles focusing on regulatory aspects and 
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primarily in connection to reproductive technologies, but also cloning and 
prenatal tests are fields of applications that committees appears in connection to. 
  
Patients or their relatives are articulated in altogether 8% of the articles. It is 
most frequently the patient organisations, which are articulated as actors (5%), 
but also individual patients (3%) and their relatives (2%) appear every now and 
then. From table G it appears that relatives are frequently articulated as authors 
of opinion pieces, whereas actual patients and the patient organisations mostly 
appear in news articles written by journalists. From figure 8 it can be seen that 
this group is primarily articulated in connection to routine use of technologies 
and also in relation to applied science. Concerning different fields of application 
it can be seen from table H that patients and relatives most often appear in 
connection to prenatal tests and gene therapy.  
 
Finally, the group of administrators are articulated in 5% of the articles and this 
is almost completely in journalistically written news. Apparently administrators 
do not write opinion pieces as administrators, but they do appear every now and 
then in news articles. They are to a large degree associated to applied research, 
whereas they are not associated to basic research. Furthermore it can be seen 
from table H that they primarily appear in relation to the applications of gene 
therapy and genetic tests (both prenatal and postnatal). 
 
 
Controversial issues 
In the present analysis, controversy has been interpreted as a question of 
whether biotechnology is presented as a problem or a solution. The more 
biotechnology is presented as both a problem and a solution, the higher the 
amount of controversy. As a practical definition of this I have designed a 
category measuring whether the article interprets the biotechnological 
application in question in a positive, negative or neutral way. The overall picture 
reveals that 43% of the articles must be said to be positive, that is, presenting 
biotechnology as a solution to problems, 27 % are negative, that is, presenting 
biotechnology as posing more problems than solutions and finally 30% must be 
said to be neutral. It should be observed that in the following figures the 
category of neutral includes all the articles that did not have a clear positive or 
negative interpretation. Therefore it is not necessarily a measure of less 
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controversy, but can be taken to imply either that the article is neutral or diffuse, 
or that several interpretations are presented in the same article.  
 
Figure 9: Interpretation and editorial type
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Since controversy, as mentioned, could be regarded as a news value in itself I 
will start by examining a few editorial variables in terms of their presentation of 
biotechnology. Figure 9 shows that news is more positive towards 
biotechnology than views (opinion pieces and editorials). This is not very 
strange as it is probably one of the strong criteria for writing and publishing an 
opinion piece that something is being problematised. But it should be noticed 
that more than half of the opinion pieces are explicitly interpreting 
biotechnology as a problem rather than as a solution. It can also be noticed from 
figure 9 that longer news articles are less positive than shorter. Furthermore, it 
appears from figure K in appendix B that front page news are more positive than 
articles placed elsewhere in papers, although the difference is not huge. To 
expand on this, it appears from figure L that the more fields of applications an 
article associate, the less positive it is and the more neutral (and possibly also 
diffuse) it becomes. A strong interpretation of this is that complexity increases 
controversy. 
 
Figure 10 demonstrates the association between interpretation of biotechnology 
and the different fields of applications mentioned in the article. Since many 
articles cover more than one field of application, I have supplemented figure 10 
with figure M in appendix B, which only includes articles that covers only one 
field of application.  
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Figure 10: Interpretation and different 
applications
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The most noticeable observation from figure 10 and figure N is that all fields of 
application can be interpreted as posing problems instead of solutions, and 
therefore we must conclude that all fields of application is to a certain extent 
presented as controversial. It also appears that applications associated with 
human reproduction, such as Cloning, Reproductive technologies and Prenatal 
tests are interpreted most negatively. Similarly it can be seen from figure N in 
appendix B that these three fields of application are the ones that are discussed 
rather more frequently in opinion pieces than in news articles. On this 
background it is probably fair to say, that when biotechnology is discussed as a 
means to control or change human reproduction it is most controversial.  
 
Furthermore it appears from figure M that when articulated as a single issue, the 
application of postnatal tests is also viewed relatively more negative than when 
covered in connection to other technologies (as in figure 10). This is probably 
because it is often associated together with human genome mapping where the 
interpretation of biotechnology is relatively more positive. Exactly the opposite 
is true of gene therapy and animal experiments, which seems to be interpreted 
more positively when they are the only issues in an article than when they are 
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associated to other issues. In the case of animal experiments this is probably due 
to the fact that this field of application is very often articulated together with 
cloning where the interpretation is much more negative. 
 
Pharmaceutical uses can be seen to be the field of application, which is most 
often interpreted in a positive fashion as a solution to problems. This is even 
more evident from figure M (but it should be taken into account that in figure M 
the total number of articles that articulate pharmaceutical use as single issue is 
rather low, n=12). And finally, the articulation of human genome mapping can 
also be seen to be a bit more positive than the average, with no difference 
whether it is covered as single issue or as one among several fields of 
application.  
 
Figure 11: Interpretation and techno-scientific 
stages
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The understanding of controversial issues is further expanded by figure 11, 
which displays how biotechnology is interpreted either positively or nega-tively 
when the focus is on different techno-scientific stages. The category of basic 
research has been divided in two because it appeared that articles presenting 
particular new discoveries are rather more positive than articles presenting basic 
research in general. And whereas applied science is less often articulated 
positively, the articulation could also be seen to be more ambiguous (higher 
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frequency of neutral) than in the case of basic research, where articles less often 
present biotechnology ambiguously.  
 
It also appears from figure 11 that it is when biotechnology is associated to 
issues of public regulation that it is interpreted as most problematic. This is not 
strange, since the category itself implies that regulation might be necessary. 
More interesting is, however, that routine use is interpreted more negatively than 
all the different stages of research. From this it can be concluded that 
biotechnology does not become less controversial when it becomes an 
established practice. Rather than breeding less controversy, it seems that 
familiarity and routine use makes biotechnology more contested. In this 
connection it should be observed from figure O in appendix B that it is also 
relatively more frequent for views to focus on routine use and public regulation 
than the other technoscientific stages.  
 
Figure 12: Health problems and interpretations
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Ca
nc
er
Inh
eri
tab
le 
dis
ea
se
s
No
rm
ali
ty
Re
pro
du
cti
on
Ne
uro
log
y a
nd
 de
me
nti
a
He
art
dis
ea
se
Ps
yc
iat
ry
Di
ab
ete
s
Inf
ec
tio
ns
Rh
eu
ma
tis
m 
etc
.
No
t s
pe
cif
ied
Negative
Neutral
Positive
 
Figure 12 shows that all identified health problems can be associated to negative 
interpretations of biotechnology, although it is not very common with 
Neurological diseases, Heart diseases, Diabetes, Infections and rheumatism. 
Cancer is close to average, but Psychiatric diseases seems to pose a particular 
case, where biotechnology is considered more problematic than with the other 
groups of diseases. Traditionally known inheritable diseases are also articulated 
in association to rather more negative interpretations, but changes to normality 
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as well as solutions to reproductive problems are the most controversial issues. 
In the case of reproductive problems the number of negative articles outweigh 
the number of positive. Furthermore it should also be noticed that articles, where 
no diseases are specified, also appears to interpret biotechnology rather 
negatively. It is therefore evident that articulating a somatic health problem is 
far more often associated to positive articulation than no specification of 
problems or association to normality or reproductive problems. 
 
Figure 13: Actors and interpretations
- single-actor articles
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Figure 13 reveals the associations between different actor groups and the 
interpretation of biotechnology. This association is not straight forward, as most 
articles presents several actors and one of them can therefore easily be 
presenting divergent interpretations than the rest. I have therefore chosen only to 
include articles articulating a single actor in figure 13. As it can be observed 
from figure Q, however, single-actor articles are more polarised and less often 
neutral in interpretation. Thus, the selection of single-actor articles displays a 
more polarised picture than the whole collection of articles. In appendix B, 
therefore, I have included table P, where it is possible to view the interpretative 
frequencies for all articles. Especially with regard to the three groups of 
Politicians, Advisory boards and Patients & relatives, figure 13 differs rather 
much from table P. When these three groups are associated with other actors 
they are much more frequently articulated in articles where the overall 
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interpretation is neutral or diffuse. When they are single actors in an article, 
however, the interpretations put forward are much more polarised. 
 
Furthermore, it should be observed in figure 13 that the two largest groups of 
actors (Researchers & health care professionals and Professionals & Citizens) 
have been split into the original categories. This division is due to the fact that 
there were rather large internal differences between the categories in these 
groups and furthermore these two groups were large enough to be split. 
  
From figure 13 it appears that members of advisory boards (primarily the 
Council of Ethics) appears to be the most critical. Also Danish social scientist, 
Citizens and Patients are primarily appearing in articles that interpret 
biotechnology rather negatively. Politicians and Professionals seem to be 
equally divided between generally positive and negative accounts. For both 
actor groups it appears from table P that when they appear in multi-actor 
articles, these are more often neutral or diffuse. Celebrities and health care 
professionals appear in articles that are slightly more often positive than 
negative. But most positive is the articles where Danish medical and natural 
scientists, international scientists and business & organisations appear. 
 
An overall comparison between figure 13 and table P gives the impression that 
most actors are articulated in articles that present both positive and negative 
interpretations of biotechnology, although some actors are primarily associated 
to positive interpretations (scientists and business) and other to negative 
interpretations (Advisory Boards, Danish social scientists, citizens and patients). 
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Conclusion 
Biotechnology has been covered as an issue of controversy throughout the 
period between August 1997 and January 2002. From the present analysis it is 
evident that all the different applications of biotechnology identified in this 
chapter can be articulated as controversial, although it is more frequent with 
some of them. Two thirds of the articles articulate a concrete problem to be 
solved by biotechnology. In this context it is far more frequent that somatic 
health problems are associated to a positive interpretation of biotechnology, than 
changes in normality and reproductive problems. Also articles mentioning no 
specific problems appear to be more critical. On a general level, natural and 
medical scientists are by far the most frequently articulated kind of actors in the 
articles. Together with business and organisations they tend to be articulated in 
articles with an overall positive interpretation of biotechnology, whereas 
advisory boards, social scientists, citizens and patients tend to be associated to 
negative interpretations. 
 
Revolutionary or far-reaching uses of biotechnology receive most attention and 
human cloning is the field of application, which has been articulated in most 
articles throughout the period. Together with the applications of prenatal tests 
and other reproductive technologies it forms an area of biotechnology which is 
often articulated with a focus on routine use of these technologies at the same 
time as it is interpreted as highly controversial. Actors associated to this 
articulation are often Advisory boards, Politicians and Professionals and 
citizens. In comparison it is relatively rarely researchers and health care 
professionals. 
 
Similar to cloning, the articulation of gene therapy is concentrated in spectacular 
case stories that receive a large amount of articulation in few months. In contrast 
to cloning, this application is articulated rather positively and even more so, 
when it is the single issue in an article than when it is associated to other 
applications. Finally, it is very often associated to cancer. Gene therapy can 
therefore be seen as a prime example on a field of application associated to 
applied medical science, with the aim of creating solutions to problems of 
serious disease. 
 
In contrast to cloning and gene therapy, other types of application, such as 
genome mapping and genetic tests, seem to receive attention on a much more 
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stable basis. For instance, genome mapping is articulated in a continuous stream 
in the mass media. It never receives extremely high amounts of attention but the 
issue is articulated in many different contexts and in association to most of the 
other fields of application. Also genetic tests are frequently articulated, and it 
appeared sensible to distinguish between the articulation of prenatal, postnatal 
and forensic tests. Whereas prenatal tests were primarily articulated as 
controversial because of their linkage to eugenics and selection, forensic tests 
were controversial with regards to the protection of privacy in a constitutional 
state. In contrast to this, postnatal tests were primarily articulated as a 
technology for individual consumption. Altogether t seems that the mapping and 
exploration of the human genome as well as the application of this knowledge in 
post-natal genetic tests and gene therapy is not as controversial as the use of 
biotechnology in matters of reproduction. 
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Appendix A: Code scheme 
 
A.   Løbenr. 
 
A1. Rubrik 
 
B. Dato: 
  
U. Tid: måned/år 
  
C. Medie:  
1. Politiken 
2. Ekstra Bladet 
3. Aktuelt 
4. Jyllandsposten 
5. Information 
 
D. Placering: 
1. Forsiden 
2. Første sektion 
3. Andre sektioner 
 
E. Genre: 
1. Redak. art. kort 
2. Redak. art. mellem 
3. Redak. art. lang 
4. Debat kort 
5. Debat mellem 
6. Debat lang 
7. Leder 
8. Anmeldelser 
9. Andet 
 
F. Geografi: 
1. Danmark 
2. Europa 
3. USA 
4. Resten af verden 
 
G. Gen-teknologisk område (ikke udeluk) 
1. Dyreforsøg og dyrs genom 
2. Identifikation af hum. gener og mutationer 
3. Medicinfremstilling eller –anvendelse 
4. Genetiske test på humane fostre og æg 
5. Genetiske tests på fødte mennesker 
6. Genetisk screening 
7. Andre reproduktions-teknologier 
8. Human kloning 
9. Human genterapi (og gensplejsning) 
10. Andet 
 
H. Sygdomme (Ikke udeluk) 
1. Traditionelt kendte medfødte sygdomme 
2. Kræft 
3. Hjerte/kar 
4. Sukkersyge 
5. Astma/Allergier 
6. Gigt/bevægeapparat 
7. Fedme/stofskiftesygd. 
8. Demens/neurologiske 
9. Psykiatri 
10. Infektionssygdomme 
11. Reproduktion 
12. Normalegenskaber 
13. Andre sygdomme 
14. Ikke specificeret 
15. Ikke syg/sund.relat 
 
I. Fokus  
1. Grundforskning  
2. Anvendt forskning  
3. Off. regulering  
4. Rutinemæs. anv. 
5. Baggrund 
 
I2: hvis grundforskning 
1. Ny opdagelse af gener/mutation/tekn 
2. Kortlægning og patentering af gener 
 
K. Hovedindtryk: 
1. Positiv 
2. Negativ 
3. Neutral/diffus 
 
L. Antal aktører: 
1. En 
2. To 
3. Tre 
4. Fire 
5. Fem 
6. Seks 
7. Seks+ 
8. Ingen 
 
N. Aktør-roller 
1. Genetiske forskere og. selskaber/foren. 
2. Andre læger og medicinske selskaber 
3. Andre naturvid. forskere  
4. Hum/Sam forskere 
5. Udenlandske forskere 
6. Sundhedsprof. 
 
7. Det Etiske Råd 
8. Teknologirådet 
9. Videnskabsetiske komiteer 
 
10. Sundhedsminister og –ministerium 
10a. Forskningsminister mv. 
11. Sundhedsstyrelsen 
12. Andre embedsmænd 
 
13. Regeringsmedlemmer 
14. Folketingets sundhedsudvalg 
14a. Folketingets forskningsudvalg 
15. Øvr. danske politikere 
16. EU-aktører 
17. Udland. politikere 
 
 
18. Sygdoms- og patientforeninger 
19. Patienter 
20. Pårørende 
 
  43
21. Arbejdsmarkedsorg. 
22. Virksomheder (DK) 
23. Virksomheder (udl.) 
24. Andre organisationer 
25. Professionelle (ikke sundheds.) 
26. Kendte og kulturpers. 
27. Konkrete borgere 
28. Statistiske befolk-ningsundersøgelser 
 
29. Sundhedsvid.fagblade og -tidsskrifter 
30. Udl. videnskabelige. tidsskrifter 
31. Andre medier 
 
32. Andre roller 
33. Ingen roller 
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Appendix B: Tables and figures 
 
Figures A1-A8: graph with monthly coverage of each technology 
Table B: Associations of fields of application 
Table C: Associations of fields of application and problems 
Figure D: Geographic origin of stories 
Table E: Geographic origin and applications  
Table F: Geographic origin and problems 
Table G: Actors and journalistic genre 
Table H: Actors and different fields of application 
Figure K: Interpretation in different sections of paper 
Figure L: Interpretation and number of applications in each article 
Figure M: Interpretation in single-application articles 
Figure N: Applications in news and views 
Figure O: Techno-scientific stages in news and views 
Table P: Interpretations and actors 
Figure Q: Interpretation and number of actors 
Figure R: Interpretation and geographic origin 
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Figure A1: Cloning  
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Figure A2: Human genome mapping 
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Figure A3: Animal experiments 
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Figure A4: Human gene therapy 
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Figure A5: Prenatal tests 
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Figure A6: Postnatal tests 
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Figure A7: Other reproductive technologies 
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Figure A8: Pharmaceutical production and use 
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Table B: Associations in fields of application 
 
Cloning Genome 
mapping 
Animal 
experiments
Gene 
therapy 
Prenatal 
tests 
Postnatal 
tests 
Repro-
technologies 
Pharma 
use 
N 
Human 
cloning 
 6% 35% 10% 13% 5% 15% 7% 341 
Genome 
mapping 
7%  17% 15% 12% 23% 6% 14% 318 
Animal 
experiments 
45% 20%  18% 12% 8% 14% 18% 268 
Gene 
therapy 
13% 19% 18%  13% 8% 13% 8% 261 
Prenatal 
tests 
19% 16% 14% 15%  18% 23% 4% 226 
Postnatal 
tests 
10% 42% 12% 12% 23%  10% 11% 177 
Reproductive 
technologies 
36% 13% 26% 24% 37% 13%  4% 141 
Pharmaceu-
tical use 
21% 41% 42% 20% 8% 18% 5%  111 
 
 
Table C: Associations in fields of application and problems 
 
Cloning Genome 
mapping 
Animal 
experiments
Gene 
therapy
Prenatal 
tests 
Postnatal 
tests 
Repro-
technologies 
Pharma 
use 
N 
Cancer 13% 28% 11% 52% 8% 24% 6% 12% 289
Inheritable diseases 14% 22% 20% 16% 57% 24% 15% 12% 206
Normality 26% 51% 25% 24% 24% 13% 13% 11% 189
Reproduction 61% 5% 32% 8% 15% 7% 40% 2% 183
Neurology/dementia 55% 27% 39% 15% 21% 20% 12% 22% 100
Heartdiseases 36% 33% 30% 20% 18% 32% 5% 23% 66 
Psychiatry 6% 77% 9% 9% 9% 25% 6% 20% 64 
Diabetes 44% 37% 31% 26% 21% 24% 13% 27% 62 
Infections 18% 46% 28% 38% 14% 24% 6% 22% 50 
Rheumatism etc. 39% 33% 39% 12% 21% 24% 9% 21% 33 
Asthma/allergies 0% 77% 15% 31% 8% 46% 15% 23% 13 
Obesity 8% 83% 17% 25% 17% 50% 25% 33% 12 
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Figure D: 
 
Figure D: Geographic origin of stories
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Figure E 
 
Figure E: Geographic origin and fields of 
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Figure F 
 
Figure F: Geographic origin and problems
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Table G: Actors and genre 
    News Views Single-actor 
Research and health care 759 65%  83% 11% 24% 
Danish scientists 427 36%  87% 8% 19% 
Danish social scientists 89 8%  58% 36% 39% 
International researchers 371 32%  92% 4% 14% 
Health care professionals 67 6%  91% 8% 18% 
       
Professionals & citizens 311 27%  53% 30% 42% 
Professionals 120 10%  75% 5% 23% 
Celebrities 69 6%  61% 7% 30% 
Citizens 147 13%  34% 57% 57% 
       
Business and organisations 231 20%  91% 6% 11% 
Danish firms 71 6%  92% 3% 13% 
International firms 135 12%  94% 6% 7% 
Organised interests 63 5%  89% 6% 11% 
       
Politicians 216 19%  89% 8% 13% 
Cabinet members 60 5%  92% 4% 8% 
Danish MPs 92 8%  87% 9% 15% 
International politicians 107 9%  93% 5% 8% 
       
Advisory Boards  139 12%  87% 12% 13% 
The Ethical Council 111 9%  85% 14% 14% 
Board of Technology 9 1%    11% 
Research ethics commitees 27 2%  96% 4% 4% 
       
Patients 92 8%  84% 12% 21% 
Patient organisations 53 5%  89% 8% 13% 
Patients 30 3%  83% 7% 20% 
Relatives 25 2%  76% 20% 24% 
       
Administration 61 5%  98% 2% 7% 
Besides the categories of news and views there was a third, consisting of reviews, announcements and so forth. 
  53
Table H: Actors and different fields of application 
 Cloning 
Human 
genome 
map. 
animal 
experiments
Gene 
therapy
Prenatal 
tests 
Postnatal 
tests 
Reproductive 
technologies
Pharma-
ceutical 
use 
Research & health care 52% 76% 68% 71% 65% 75% 57% 70% 
Professionals & citizens 35% 22% 26% 17% 29% 25% 34% 20% 
Business & organisations 18% 26% 28% 16% 10% 21% 15% 52% 
Politicians 30% 12% 17% 18% 11% 18% 18% 13% 
Committees 18% 8% 9% 13% 18% 15% 21% 5% 
Patients 3% 8% 2% 11% 16% 6% 4% 1% 
Administration 3% 2% 2% 8% 8% 8% 4% 3% 
N 341 318 268 261 226 177 141 111 
The table should be read so that of the 341 articles covering human cloning, 52% feature an actor in the group of 
research and health care. 
 
 
Figure K 
Figure K: Interpretation in different sections 
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Figure L 
Figure L: Interpretation and number of 
applications in each article
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Figure M 
Figure M: Interpretation in single-application 
articles
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Figure N 
Figure N: Applications in news and views
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Figure O 
Figure O: Techno-scientific stages in news and 
views
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Table P Positive Neutral Negative 
Research & health care 49% 30% 21%
Danish scientists 54% 30% 16%
Danish social scientists 20% 42% 38%
International researchers 48% 31% 22%
Health care professionals 48% 27% 25%
Professionals & citizens 34% 33% 33%
Professionals 38% 38% 24%
Celebrities 28% 49% 23%
Citizens 31% 26% 44%
Business & organisations 43% 31% 26%
Danish firms 49% 32% 18%
International firms 50% 29% 21%
Organised interests 33% 29% 38%
Politicians 25% 49% 26%
Cabinet members 23% 48% 28%
Danish MP's 27% 47% 26%
International politicians 23% 50% 26%
Advisory Boards 17% 51% 32%
The Ethical Council 12% 54% 34%
Board of Technology 33% 56% 11%
Research Ethics Committees 30% 44% 26%
Patients 34% 33% 34%
Patient organisations 36% 34% 30%
Patients 27% 30% 43%
Relatives 24% 40% 36%
Administration 33% 54% 13%
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Figure Q 
 
Figure Q: Interpretation and number of actors
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Figure R 
 
Figure R: Interpretation and geographic origin
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